weight regain tirzepatide after the withdrawal of (Zepbound) may wipe out many of the cardiometabolic gains made during weight loss, a post-hoc analysis of the SURMOUNT-4 trial indicated. Read more at: https://www.medpagetoday.com/endocrinology/obesity Tirzepatide Demonstrates Sustained Weight Loss

The impact of tirzepatide and glucagon-like peptide-1 receptor agonists on oral contraceptive exposure

The average deductible amounts for covered workers in plans with separate per-person annual deductibles for family coverage are $1,635 for PPOs, and $4,055 for HDHP/SOs [Figure 7.21]

The FDA has received reports suggesting that some adverse events were linked to compounded doses that differed from standard, branded doses

This allows for higher concentrations of nutrients and ensures optimal absorption, especially for those with compromised gut health

In the STEP 1 Study that only enrolled nondiabetics, Wegovy did not increase the risk of hypoglycemia